Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
635.45
+6.72 (1.07%)
At close: Jun 5, 2026, 4:00 PM EDT
635.00
-0.45 (-0.07%)
After-hours: Jun 5, 2026, 7:53 PM EDT
Regeneron Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $855 | Buy | Maintains | $855 | +34.55% | Jun 2, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $730 | Buy | Maintains | $730 | +14.88% | May 21, 2026 |
| Scotiabank | Scotiabank | Hold Maintains $770 | Hold | Maintains | $770 | +21.17% | May 19, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $1,057 → $875 | Buy | Maintains | $1,057 → $875 | +37.70% | May 19, 2026 |
| Wolfe Research | Wolfe Research | Buy Reiterates $860 | Buy | Reiterates | $860 | +35.34% | May 18, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $875 → $825 | Buy | Maintains | $875 → $825 | +29.83% | May 18, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $968 | Buy | Maintains | $968 | +52.33% | May 18, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $762 → $707 | Hold | Maintains | $762 → $707 | +11.26% | May 18, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.